# Beta Bionics, Inc. (BBNX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BBNX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 27.63M | $ -21.90M | $ -25.21M | $ 6.91M | $ 271.25M |
| 2025 | $ 102.65M | $ -74.95M | $ -57.57M | $ 7.30M | $ 287.61M |
| 2024 | $ 68.45M | $ -57.55M | $ -54.31M | $ 7.26M | $ 76.01M |
| 2023 | $ 12.37M | $ -29.76M | $ -7.20M | $ 4.22M | $ 58.61M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 10.69 |

## Other views

- [Metrics](https://sponda.capital/en/BBNX.md)
- [Charts](https://sponda.capital/en/BBNX/charts.md)
- [Compare](https://sponda.capital/en/BBNX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.